Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media






Home
Bias Split
Public FiguresControversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!

How our sliders workAboutContact UsNewsletter Archive
MediaFAQGlossaryPrivacy Policy
  1. Home

Moderna: Omicron Booster Effective Against New Subvariants

  • #Diseases & conditions
  • #Medicine & healthcare
  • #COVID-19
  • #Healthcare
  • #World
story
NOV 2022
Image copyright: Getty Images [via Time]
story last updated NOV 2022

The Spin

Narrative A

Granted, the first vaccines produced for COVID weren't the perfect long-term solution, but it's important to remain agile to fine-tune current vaccines for a rapidly-evolving virus. When we add more options to the toolkit, personal and collective decision-making processes also improve — this is vital in the fight against variants.

NEJM

Narrative B

Current COVID vaccines and boosters don't prevent people from becoming infected and don't fully stop long-COVID — these jabs were designed to reduce the disease severity and hospitalization. Perhaps it's time to focus fully on a "v2.0" vaccine to protect against all variants, block transmission, and prevent long-COVID. This upgrade, instead of tweaking what we have now, would go a long way in helping people to calculate their own risk.

Time

Establishment-critical narrative

While Moderna — along with Pfizer and other drug companies — should be commended for the speed and efficiency with which they initially developed vaccines against COVID, they've also acted as shameless profiteers, taking advantage of the crisis to rake in absurd profits. Their endless development of boosters is just a small part of this. More must be done to limit their excessive gains that come at great public expense.

Politico

Metaculus Prediction


Establishment split

CRITICAL

PRO

Moderna's Omicron Booster Works Against New Variants, Company Says
TimeAUG 2022
Moderna says its updated booster raises antibodies against omicron subvariants
NBCAUG 2022
New Covid Booster Strengthens Immune Response Against Subvariants, Moderna Says
New York TimesAUG 2022
Moderna says new booster increases protection against omicron subvariants
Washington PostAUG 2022
White House to seek more covid funding in lame-duck session
Washington PostAUG 2022
Moderna’s New Covid-19 Booster Produced Strong Immune Response in Study
Wall Street JournalAUG 2022
NBC News Admits Anti-Vaxxers Were Right About COVID Shots Causing Myocarditis
InfoWarsAUG 2022

More neutral establishment stance articles

Study discovers three times higher chance of myocarditis in Moderna vaccines than Pfizer
One AmericaAUG 2022